Product
reparixin
1 clinical trial
3 indications
Indication
MyelofibrosisClinical trial
Phase II Study of Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium [MPN-RC 120]Status: Recruiting, Estimated PCD: 2025-03-01